 | • レポートコード：QYR9N7330 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、副甲状腺機能低下症の治療のグローバル市場について調査・分析したレポートで、種類別（経口、非経口）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・副甲状腺機能低下症の治療の世界市場規模 ・主要企業別市場シェア ・副甲状腺機能低下症の治療の世界市場規模：種類別（経口、非経口） ・副甲状腺機能低下症の治療の世界市場規模：用途別（病院薬局、小売薬局、オンライン薬局） ・副甲状腺機能低下症の治療のアメリカ市場規模（種類別、用途別） ・副甲状腺機能低下症の治療のヨーロッパ市場規模（種類別、用途別） ・副甲状腺機能低下症の治療の中国市場規模（種類別、用途別） ・副甲状腺機能低下症の治療の日本市場規模（種類別、用途別） ・副甲状腺機能低下症の治療の東南アジア市場規模（種類別、用途別） ・副甲状腺機能低下症の治療のインド市場規模（種類別、用途別） ・副甲状腺機能低下症の治療の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・副甲状腺機能低下症の治療の世界市場予測（2019年-2025年） ・副甲状腺機能低下症の治療の地域別市場予測（2019年-2025年） ... |
In 2018, the global Hypoparathyroidism Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Hypoparathyroidism Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hypoparathyroidism Treatment development in United States, Europe and China.
The key players covered in this study
Shire
Roche
Entera Bio
Teva Pharmaceuticals
Sun Pharmaceutical
AbbVie
GlaxoSmithKline
Takeda Pharmaceutical
Market segment by Type, the product can be split into
Oral
Parenteral
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hypoparathyroidism Treatment status, future forecast, growth opportunity, key market and key players.
To present the Hypoparathyroidism Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hypoparathyroidism Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hypoparathyroidism Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral
1.4.3 Parenteral
1.5 Market by Application
1.5.1 Global Hypoparathyroidism Treatment Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Hypoparathyroidism Treatment Market Size
2.2 Hypoparathyroidism Treatment Growth Trends by Regions
2.2.1 Hypoparathyroidism Treatment Market Size by Regions (2014-2025)
2.2.2 Hypoparathyroidism Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Hypoparathyroidism Treatment Market Size by Manufacturers
3.1.1 Global Hypoparathyroidism Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Hypoparathyroidism Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hypoparathyroidism Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Hypoparathyroidism Treatment Key Players Head office and Area Served
3.3 Key Players Hypoparathyroidism Treatment Product/Solution/Service
3.4 Date of Enter into Hypoparathyroidism Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Hypoparathyroidism Treatment Market Size by Type (2014-2019)
4.2 Global Hypoparathyroidism Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Hypoparathyroidism Treatment Market Size (2014-2019)
5.2 Hypoparathyroidism Treatment Key Players in United States
5.3 United States Hypoparathyroidism Treatment Market Size by Type
5.4 United States Hypoparathyroidism Treatment Market Size by Application
6 Europe
6.1 Europe Hypoparathyroidism Treatment Market Size (2014-2019)
6.2 Hypoparathyroidism Treatment Key Players in Europe
6.3 Europe Hypoparathyroidism Treatment Market Size by Type
6.4 Europe Hypoparathyroidism Treatment Market Size by Application
7 China
7.1 China Hypoparathyroidism Treatment Market Size (2014-2019)
7.2 Hypoparathyroidism Treatment Key Players in China
7.3 China Hypoparathyroidism Treatment Market Size by Type
7.4 China Hypoparathyroidism Treatment Market Size by Application
8 Japan
8.1 Japan Hypoparathyroidism Treatment Market Size (2014-2019)
8.2 Hypoparathyroidism Treatment Key Players in Japan
8.3 Japan Hypoparathyroidism Treatment Market Size by Type
8.4 Japan Hypoparathyroidism Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Hypoparathyroidism Treatment Market Size (2014-2019)
9.2 Hypoparathyroidism Treatment Key Players in Southeast Asia
9.3 Southeast Asia Hypoparathyroidism Treatment Market Size by Type
9.4 Southeast Asia Hypoparathyroidism Treatment Market Size by Application
10 India
10.1 India Hypoparathyroidism Treatment Market Size (2014-2019)
10.2 Hypoparathyroidism Treatment Key Players in India
10.3 India Hypoparathyroidism Treatment Market Size by Type
10.4 India Hypoparathyroidism Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Hypoparathyroidism Treatment Market Size (2014-2019)
11.2 Hypoparathyroidism Treatment Key Players in Central & South America
11.3 Central & South America Hypoparathyroidism Treatment Market Size by Type
11.4 Central & South America Hypoparathyroidism Treatment Market Size by Application
12 International Players Profiles
12.1 Shire
12.1.1 Shire Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hypoparathyroidism Treatment Introduction
12.1.4 Shire Revenue in Hypoparathyroidism Treatment Business (2014-2019)
12.1.5 Shire Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hypoparathyroidism Treatment Introduction
12.2.4 Roche Revenue in Hypoparathyroidism Treatment Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Entera Bio
12.3.1 Entera Bio Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hypoparathyroidism Treatment Introduction
12.3.4 Entera Bio Revenue in Hypoparathyroidism Treatment Business (2014-2019)
12.3.5 Entera Bio Recent Development
12.4 Teva Pharmaceuticals
12.4.1 Teva Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hypoparathyroidism Treatment Introduction
12.4.4 Teva Pharmaceuticals Revenue in Hypoparathyroidism Treatment Business (2014-2019)
12.4.5 Teva Pharmaceuticals Recent Development
12.5 Sun Pharmaceutical
12.5.1 Sun Pharmaceutical Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hypoparathyroidism Treatment Introduction
12.5.4 Sun Pharmaceutical Revenue in Hypoparathyroidism Treatment Business (2014-2019)
12.5.5 Sun Pharmaceutical Recent Development
12.6 AbbVie
12.6.1 AbbVie Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hypoparathyroidism Treatment Introduction
12.6.4 AbbVie Revenue in Hypoparathyroidism Treatment Business (2014-2019)
12.6.5 AbbVie Recent Development
12.7 GlaxoSmithKline
12.7.1 GlaxoSmithKline Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hypoparathyroidism Treatment Introduction
12.7.4 GlaxoSmithKline Revenue in Hypoparathyroidism Treatment Business (2014-2019)
12.7.5 GlaxoSmithKline Recent Development
12.8 Takeda Pharmaceutical
12.8.1 Takeda Pharmaceutical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hypoparathyroidism Treatment Introduction
12.8.4 Takeda Pharmaceutical Revenue in Hypoparathyroidism Treatment Business (2014-2019)
12.8.5 Takeda Pharmaceutical Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Hypoparathyroidism Treatment Key Market Segments
Table Key Players Hypoparathyroidism Treatment Covered
Table Global Hypoparathyroidism Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Hypoparathyroidism Treatment Market Size Market Share by Type 2014-2025
Figure Oral Figures
Table Key Players of Oral
Figure Parenteral Figures
Table Key Players of Parenteral
Table Global Hypoparathyroidism Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Hypoparathyroidism Treatment Report Years Considered
Table Global Hypoparathyroidism Treatment Market Size 2014-2025 (Million US$)
Figure Global Hypoparathyroidism Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hypoparathyroidism Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Hypoparathyroidism Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Hypoparathyroidism Treatment Market Share by Regions 2014-2019
Figure Global Hypoparathyroidism Treatment Market Share by Regions 2014-2019
Figure Global Hypoparathyroidism Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Hypoparathyroidism Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Hypoparathyroidism Treatment Market Share by Manufacturers (2014-2019)
Figure Global Hypoparathyroidism Treatment Market Share by Manufacturers in 2018
Table Global Hypoparathyroidism Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hypoparathyroidism Treatment Product/Solution/Service
Table Date of Enter into Hypoparathyroidism Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hypoparathyroidism Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Hypoparathyroidism Treatment Market Size Share by Type (2014-2019)
Figure Global Hypoparathyroidism Treatment Market Size Market Share by Type (2014-2019)
Table Global Hypoparathyroidism Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Hypoparathyroidism Treatment Market Size Share by Application (2014-2019)
Figure Global Hypoparathyroidism Treatment Market Size Market Share by Application (2014-2019)
Figure Global Hypoparathyroidism Treatment Revenue Market Share by Application in 2018
Figure United States Hypoparathyroidism Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Hypoparathyroidism Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Hypoparathyroidism Treatment Market Share (2018-2019)
Table United States Hypoparathyroidism Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Hypoparathyroidism Treatment Market Share by Type (2014-2019)
Table United States Hypoparathyroidism Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Hypoparathyroidism Treatment Market Share by Application (2014-2019)
Figure Europe Hypoparathyroidism Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Hypoparathyroidism Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Hypoparathyroidism Treatment Market Share (2018-2019)
Table Europe Hypoparathyroidism Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Hypoparathyroidism Treatment Market Share by Type (2014-2019)
Table Europe Hypoparathyroidism Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Hypoparathyroidism Treatment Market Share by Application (2014-2019)
Figure China Hypoparathyroidism Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Hypoparathyroidism Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Hypoparathyroidism Treatment Market Share (2018-2019)
Table China Hypoparathyroidism Treatment Market Size by Type (2014-20189) (Million US$)
Table China Hypoparathyroidism Treatment Market Share by Type (2014-2019)
Table China Hypoparathyroidism Treatment Market Size by Application (2014-2019) (Million US$)
Table China Hypoparathyroidism Treatment Market Share by Application (2014-2019)
Figure Japan Hypoparathyroidism Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Hypoparathyroidism Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Hypoparathyroidism Treatment Market Share (2018-2019)
Table Japan Hypoparathyroidism Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Hypoparathyroidism Treatment Market Share by Type (2014-2019)
Table Japan Hypoparathyroidism Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Hypoparathyroidism Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Hypoparathyroidism Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hypoparathyroidism Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hypoparathyroidism Treatment Market Share (2018-2019)
Table Southeast Asia Hypoparathyroidism Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Hypoparathyroidism Treatment Market Share by Type (2014-2019)
Table Southeast Asia Hypoparathyroidism Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Hypoparathyroidism Treatment Market Share by Application (2014-2019)
Figure India Hypoparathyroidism Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Hypoparathyroidism Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Hypoparathyroidism Treatment Market Share (2018-2019)
Table India Hypoparathyroidism Treatment Market Size by Type (2014-2019) (Million US$)
Table India Hypoparathyroidism Treatment Market Share by Type (2014-2019)
Table India Hypoparathyroidism Treatment Market Size by Application (2014-2019) (Million US$)
Table India Hypoparathyroidism Treatment Market Share by Application (2014-2019)
Figure Central & South America Hypoparathyroidism Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hypoparathyroidism Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hypoparathyroidism Treatment Market Share (2018-2019)
Table Central & South America Hypoparathyroidism Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Hypoparathyroidism Treatment Market Share by Type (2014-2019)
Table Central & South America Hypoparathyroidism Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Hypoparathyroidism Treatment Market Share by Application (2014-2019)
Table Shire Company Details
Table Shire Revenue in Hypoparathyroidism Treatment Business (2014-2019) (Million US$)
Figure Shire Revenue Growth Rate in Hypoparathyroidism Treatment Business (2014-2019)
Table Shire Recent Development
Table Roche Company Details
Table Roche Revenue in Hypoparathyroidism Treatment Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Hypoparathyroidism Treatment Business (2014-2019)
Table Roche Recent Development
Table Entera Bio Company Details
Table Entera Bio Revenue in Hypoparathyroidism Treatment Business (2014-2019)(Million US$)
Figure Entera Bio Revenue Growth Rate in Hypoparathyroidism Treatment Business (2014-2019)
Table Entera Bio Recent Development
Table Teva Pharmaceuticals Company Details
Table Teva Pharmaceuticals Revenue in Hypoparathyroidism Treatment Business (2014-2019)(Million US$)
Figure Teva Pharmaceuticals Revenue Growth Rate in Hypoparathyroidism Treatment Business (2014-2019)
Table Teva Pharmaceuticals Recent Development
Table Sun Pharmaceutical Company Details
Table Sun Pharmaceutical Revenue in Hypoparathyroidism Treatment Business (2014-2019)(Million US$)
Figure Sun Pharmaceutical Revenue Growth Rate in Hypoparathyroidism Treatment Business (2014-2019)
Table Sun Pharmaceutical Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Hypoparathyroidism Treatment Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Hypoparathyroidism Treatment Business (2014-2019)
Table AbbVie Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Hypoparathyroidism Treatment Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Hypoparathyroidism Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Revenue in Hypoparathyroidism Treatment Business (2014-2019)(Million US$)
Figure Takeda Pharmaceutical Revenue Growth Rate in Hypoparathyroidism Treatment Business (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Global Hypoparathyroidism Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Hypoparathyroidism Treatment Market Size Share by Regions (2019-2025)
Figure Global Hypoparathyroidism Treatment Market Size Share by Regions in 2025
Figure United States Hypoparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hypoparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Hypoparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hypoparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hypoparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Hypoparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hypoparathyroidism Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Hypoparathyroidism Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Hypoparathyroidism Treatment Market Size by Product (2019-2025)
Figure Global Hypoparathyroidism Treatment Market Size by Product in 2025
Table Global Hypoparathyroidism Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Hypoparathyroidism Treatment Market Size by Application (2019-2025)
Figure Global Hypoparathyroidism Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のクッシング病治療市場：市場規模・現状・予測 Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…- 世界の結節性痒疹の治療市場：市場規模・現状・予測 Prurigo nodularis (PN), also known as nodular prurigo, is a skin disease characterised by pruritic (itchy) nodules which usually appear on the arms or legs.Among products, antihistamines are foreseen to exhibit a higher CAGR in the global prurigo nodularis treatment market. In 2018, the global Pruri…
- 世界の尋常性天疱瘡の治療市場：市場規模・現状・予測 Pemphigus vulgaris is a rare chronic blistering skin disease and the most common form of pemphigus.In 2018, the global Pemphigus Vulgaris Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses o…
- 世界の放射線皮膚炎の治療市場：市場規模・現状・予測 The pathophysiology of a radiation skin reaction is a combination of radiation injury and the subsequent inflammatory response and can occur at both the entrance and exit site of the irradiation.The major factor driving the radiation dermatitis treatment market is the increasing prevalence of cancer…
- 世界のサイトメガロウイルス治療市場：市場規模・現状・予測 Cytomegalovirus (CMV) is a genus of viruses in the order Herpesvirales, in the family Herpesviridae, in the subfamily Betaherpesvirinae. Humans and monkeys serve as natural hosts.In 2018, the global Cytomegalovirus Treatment market size was xx million US$ and it is expected to reach xx million US$ b…